Headlines
Bloomberg MarketsFed Chair Warsh Says US Is Seeing an Investment SurgeFinancial TimesWhat do the Houthis want?Financial TimesUS business leaders are waking up to the perils of plutopopulismFinancial TimesThe secret fight around financial flowsFinancial TimesUK government courted UBS over London HQ moveFinancial TimesIndonesia stocks plunge after MSCI says market could be cut from indicesBloomberg MarketsIndonesia Stocks Sink as MSCI Weighs Index RemovalBloomberg MarketsChina’s National Team Signals Return With Heavy ETF InflowsBloomberg MarketsCity Therapeutics Raises $200 Million in Upsized US IPOBloomberg MarketsBOE Chief Says Energy Shock Delays 2% Inflation TargetBloomberg MarketsPBOC’s Pan Touts Yuan Assets to Investors at Deutsche Bank EventBloomberg MarketsIndia’s Rupee Rebound Comes With Growing Strains in FX MarketBloomberg MarketsAustralia’s Three-Year Bond Sale Sees Highest Demand Since 2018Bloomberg MarketsIndian Software Stocks Set to Beat AI Peers by Most in DecadesBloomberg MarketsIndia IT Gains Favor as an Anti-AI Bet Despite Mixed EarningsBloomberg MarketsFed Chair Warsh Says US Is Seeing an Investment SurgeFinancial TimesWhat do the Houthis want?Financial TimesUS business leaders are waking up to the perils of plutopopulismFinancial TimesThe secret fight around financial flowsFinancial TimesUK government courted UBS over London HQ moveFinancial TimesIndonesia stocks plunge after MSCI says market could be cut from indicesBloomberg MarketsIndonesia Stocks Sink as MSCI Weighs Index RemovalBloomberg MarketsChina’s National Team Signals Return With Heavy ETF InflowsBloomberg MarketsCity Therapeutics Raises $200 Million in Upsized US IPOBloomberg MarketsBOE Chief Says Energy Shock Delays 2% Inflation TargetBloomberg MarketsPBOC’s Pan Touts Yuan Assets to Investors at Deutsche Bank EventBloomberg MarketsIndia’s Rupee Rebound Comes With Growing Strains in FX MarketBloomberg MarketsAustralia’s Three-Year Bond Sale Sees Highest Demand Since 2018Bloomberg MarketsIndian Software Stocks Set to Beat AI Peers by Most in DecadesBloomberg MarketsIndia IT Gains Favor as an Anti-AI Bet Despite Mixed Earnings
Home/Bloomberg Markets
Back
MARKETS:
SPY+0.26%
DIA+0.23%
QQQ-0.14%
IWM+0.29%
GLD-0.40%
USO+1.64%
Bloomberg Marketsglobal

City Therapeutics Raises $200 Million in Upsized US IPO

Bloomberg Markets
Friday, October 16, 2026 at 3:14 AM
~4 min read
Inflation

Original Report

City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.

Glass House Analysis

Inflation is the silent tax that erodes purchasing power, hitting hardest those who can least afford it. When grocery bills rise faster than wages, families face impossible choices between food, medicine, and rent. Unlike market volatility that mainly affects investors, inflation touches everyone who buys groceries, fills a gas tank, or pays rent.

The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.

Enjoyed this analysis?

Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.

No spam. Unsubscribe anytime.

More Stories

Economic Context

S&P 500
+0.26%
Dow Jones
+0.23%
NASDAQ 100
-0.14%
Russell 2000
+0.29%